Physician
Hematology
Dr. Craig S. Rosenfeld, MD
Dr. Craig S. Rosenfeld works in the field of Hematology. He attended University of Missouri - Kansas City School of Medicine. Dr. Craig S. Rosenfeld is also a published doctor. He has 22 publication published. The most recent publication is: Phase II study of roquinimex in myelodysplastic syndrome.
Publications
- Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.
- Clinical development of decitabine as a prototype for an epigenetic drug program.
- Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies.
- Phase II study of roquinimex in myelodysplastic syndrome.
- Autologous bone marrow transplantation following high-dose busulfan and VP-16 for advanced non-Hodgkin's lymphoma and Hodgkin's disease.
- Ex vivo purging of allogeneic marrow with L-Leucyl-L-leucine methyl ester. A phase I study.
- Potential of phenylalanine methylester as a bone marrow purging agent.
- Increased macrophage colony-stimulating factor levels in immune thrombocytopenic purpura.
- Human macrophage colony-stimulating factor induces macrophage colonies after L-phenylalanine methylester treatment of human marrow.
- In vitro evidence for disappearance of erythroid progenitor T suppressor cells following allogeneic bone marrow transplantation for severe aplastic anemia.
- High-dose intravenous gamma globulin improves responses to single-donor platelets in patients refractory to platelet transfusion.
- Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
- Cyclosporine and methylprednisolone after allogeneic marrow transplantation: association between low cyclosporine concentration and risk of acute graft-versus-host dis...
- Use of granulocyte-macrophage colony-stimulating factor in patients with malignancy and bone marrow failure.
- Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.
- Antileukemic activity of phenylalanine methyl ester (PME): a lysosomotropic peptide methyl ester.
- Pilot study of recombinant human soluble tumor necrosis factor receptor (TNFR:Fc) in patients with low risk myelodysplastic syndrome.
- Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation.
- High-dose cytosine arabinoside and L-asparaginase therapy for poor-risk adult acute nonlymphocytic leukemia. A retrospective study.
- Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes.
- Decitabine: development of a DNA methyltransferase inhibitor for hematological malignancies.
Schools
University of Missouri Kansas City Campus
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
University of Missouri - Kansas City School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Barry Cooper, MD |
|
|
Dr. Narotham R. Thudi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John C. Bagwell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marvin J. Stone, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Martin F. Dietrich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine C. Ansley, MD |
|
|
Dr. Robert W. Burns, MD
This Doctor is OpenDoctor Recommended.
|